Mettler Toledo Introduces Mechanical Analyzer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Mettler Toledo Introduces Mechanical Analyzer


The Excellence Dynamic Mechanical Analyzer DMA 1, introduced by Mettler Toledo at Pittcon 2013, offers six different deformation modes to gauge materials performance. The instrument can handle multiple dynamic and static measurements to characterize viscoelasticity, glass transition, softening, crystallization, and phase transformation, according to the press announcement.

Users can set the sample arm and analysis head at multiple angles based on sample nature and geometry. Rapid cooling to as low as -190 ºC with minimal liquid nitrogen consumption also helps improve sample throughput, reduce costs, and improve operator safety.

The linear variable differential transformer (LVDT) measures changes in length over a measurement range of ±1 mm with a mean resolution of 2 nm. The DMA 1 also offers the ability to operate in liquids or at specific relative humidity levels.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
21%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
8%
Regulatory compliance
42%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here